Detalles de la búsqueda
1.
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
Ann Rheum Dis
; 80(3): 304-311, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115760
2.
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Clin Exp Rheumatol
; 38(4): 732-741, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452344
3.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31858963
4.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
; 391(10117): 230-240, 2018 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29129436
5.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
N Engl J Med
; 375(16): 1532-1543, 2016 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27641143
6.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Rheumatol Int
; 37(9): 1469-1479, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28597306
7.
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.
Ann Rheum Dis
; 75(7): 1293-301, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275429
8.
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
Rheumatology (Oxford)
; 55(8): 1466-76, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114562
9.
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
JAMA
; 316(7): 722-33, 2016 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27533157
10.
Teriparatide vs risedronate for osteoporosis - Authors' reply.
Lancet
; 391(10133): 1896, 2018 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29781442
11.
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.
Ann Rheum Dis
; 73(8): 1477-86, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23740226
12.
Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.
Ann Rheum Dis
; 71(8): 1289-96, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22307942
13.
Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO).
Arch Endocrinol Metab
; 66(5): 591-603, 2022 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191263
14.
An updated hip fracture incidence rate for Brazil: the Brazilian Validation Osteoporosis Study (BRAVOS).
Arch Osteoporos
; 17(1): 90, 2022 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780201
15.
Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).
Arch Osteoporos
; 16(1): 49, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33646403
16.
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
J Bone Miner Res
; 36(11): 2139-2152, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34190361
17.
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Ther Adv Musculoskelet Dis
; 13: 1759720X211006964, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959198
18.
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate.
Arthritis Care Res (Hoboken)
; 72(8): 1112-1121, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31233281
19.
Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE.
Rheumatol Ther
; 7(4): 851-866, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876903
20.
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Arch Osteoporos
; 14(1): 10, 2019 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659410